Selling And Administration Expenses تغییر دادن تاریخ
AbbVie USD 3.61B 273M 2023-12
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
Astellas Pharma JPY 179.28B 11.1B 2023-09
AstraZeneca USD 3.91B 194M 2023-09
Bayer EUR 3.6B 81M 2023-09
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Daiichi Sankyo JPY 141.03B 4.45B 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Exelixis USD 138.14M 3.58M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Incyte USD 293.86M 25.97M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Merck USD 2.75B 272M 2023-12
Moderna USD 470M 28M 2023-12
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Agios Pharmaceuticals فروش و مدیریت هزینه - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2024.